drugset / Trial / NCT00525499

A Phase 2 Study of ASC-J9 Cream in Acne Vulgaris

NCT00525499 ↗

Phase 2 Completed 186 enrolled AndroScience Corp
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to evaluate if topical ASC-J9 cream is effective in treating acne.

Timeline

Start
2007-08
Primary completion
2008-04
Completion
2008-07

Drugs

EvaluationDrugModalityDoseRoute
Subject DIMETHYLCURCUMIN Small molecule 0.001 % Topical
Subject DIMETHYLCURCUMIN Small molecule 0.005 % Topical
Subject DIMETHYLCURCUMIN Small molecule 0.025 % Topical

Indications